Skip to main content
Top
Published in: Journal of Nephrology 8/2022

23-06-2022 | Hyperpigmentation | Lessons for the Clinical Nephrologist

A case of POEMS syndrome with severe kidney damage: lessons for the clinical nephrologist

Authors: Irina Rekhtina, Ekaterina Stolyarevich, Elena Zakharova, Victoria Khyshova, Larisa Mendeleeva

Published in: Journal of Nephrology | Issue 8/2022

Login to get access

Excerpt

A 46-year-old Caucasian male without previous medical history of kidney disease experienced erectile dysfunction, and wrist and foot numbness; over the following three months he developed leg pain, weakness, edema, abdominal swelling, dyspnea and dark skin. …
Appendix
Available only for authorised users
Literature
1.
go back to reference IARC (2017) WHO Classification of tumours of lymphoid and hematopoietic tissues. IARC, Lyon IARC (2017) WHO Classification of tumours of lymphoid and hematopoietic tissues. IARC, Lyon
4.
go back to reference Fajgenbaum DC, Uldrick TS, Bagg A et al (2017) International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease. Blood 129(12):1646–1657CrossRef Fajgenbaum DC, Uldrick TS, Bagg A et al (2017) International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease. Blood 129(12):1646–1657CrossRef
5.
go back to reference Modesto-Segonds A, Rey JP, Orfila C, Huchard G, Suc JM (1995) Renal involvement in POEMS syndrome. Clin Nephrol 43(5):342–345PubMed Modesto-Segonds A, Rey JP, Orfila C, Huchard G, Suc JM (1995) Renal involvement in POEMS syndrome. Clin Nephrol 43(5):342–345PubMed
6.
go back to reference Fam AG, Rubenstein JD, Cowan DH (1986) POEMS syndrome. Study of a patient with proteinuria, microangiopathic glomerulopathy and renal enlargement. Arthritis Rheum 29:233–241CrossRef Fam AG, Rubenstein JD, Cowan DH (1986) POEMS syndrome. Study of a patient with proteinuria, microangiopathic glomerulopathy and renal enlargement. Arthritis Rheum 29:233–241CrossRef
7.
go back to reference Nakamoto Y, Imai H, Yasuda T, Wakui H, Miura AB (1999) A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome. Nephrol Dial Transplant 14:2370–2378CrossRef Nakamoto Y, Imai H, Yasuda T, Wakui H, Miura AB (1999) A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome. Nephrol Dial Transplant 14:2370–2378CrossRef
8.
go back to reference Ye W, Wang C, Cai Q-Q et al (2016) Renal impairment in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes syndrome: incidence, treatment and outcome. Nephrol Dial Transplant 31:275–283PubMed Ye W, Wang C, Cai Q-Q et al (2016) Renal impairment in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes syndrome: incidence, treatment and outcome. Nephrol Dial Transplant 31:275–283PubMed
9.
go back to reference Sethi S, Nester CM, Smith RJH (2012) Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion. Kidney Int 81:434–441CrossRef Sethi S, Nester CM, Smith RJH (2012) Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion. Kidney Int 81:434–441CrossRef
Metadata
Title
A case of POEMS syndrome with severe kidney damage: lessons for the clinical nephrologist
Authors
Irina Rekhtina
Ekaterina Stolyarevich
Elena Zakharova
Victoria Khyshova
Larisa Mendeleeva
Publication date
23-06-2022
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 8/2022
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-022-01379-w

Other articles of this Issue 8/2022

Journal of Nephrology 8/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.